Clinical Trial Detail

NCT ID NCT01921751
Title High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements no
Sponsors Radiation Therapy Oncology Group
Indications

pancreatic adenocarcinoma

Therapies

Nab-paclitaxel + Gemcitabine

Capecitabine

Age Groups: adult

No variant requirements are available.